|
RNF20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25189999980557E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.52119999824652E-08 |
| Normal-vs-Stage2 |
6.601600E-03 |
| Normal-vs-Stage3 |
5.704700E-03 |
| Normal-vs-Stage4 |
1.044490E-02 |
| Stage1-vs-Stage2 |
7.491400E-01 |
| Stage1-vs-Stage3 |
5.783600E-01 |
| Stage1-vs-Stage4 |
9.108000E-01 |
| Stage2-vs-Stage3 |
8.769400E-01 |
| Stage2-vs-Stage4 |
7.113800E-01 |
| Stage3-vs-Stage4 |
6.266800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51789999961005E-07 |
| Normal-vs-AfricanAmerican |
3.10100000011637E-07 |
| Normal-vs-Asian |
1.930580E-01 |
| Caucasian-vs-AfricanAmerican |
3.340400E-01 |
| Caucasian-vs-Asian |
7.796000E-01 |
| AfricanAmerican-vs-Asian |
9.971000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50499978935193E-10 |
| Normal-vs-Female |
3.849600E-02 |
| Male-vs-Female |
3.939200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.592700E-04 |
| Normal-vs-Extreme_Weight |
1.75479630826203E-11 |
| Normal-vs-Obese |
7.024600E-03 |
| Normal-vs-Extreme_Obese |
4.145500E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.119550E-01 |
| Normal_Weight-vs-Obese |
4.231400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.280200E-01 |
| Extreme_Weight-vs-Obese |
1.190430E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.015400E-01 |
| Obese-vs-Extreme_Obese |
4.391600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.084000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.83986999999775E-05 |
| Normal-vs-Age(61-80Yrs) |
1.14039999998816E-07 |
| Normal-vs-Age(81-100Yrs) |
1.56521999999937E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.499200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.721200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.502400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.847000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.754590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.484200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85329995794348E-09 |
| Normal-VS-Type2 PRCC |
2.862400E-03 |
| Normal-VS-KIRP CIMP |
3.802600E-01 |
| Normal-VS-Unclassified PRCC |
2.835900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.930800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.839600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.778440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.572800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.166400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.595400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99109999990499E-07 |
| Normal-vs-N1 |
3.260000E-01 |
| Normal-vs-N2 |
1.650480E-02 |
| N0-vs-N1 |
5.848400E-02 |
| N0-vs-N2 |
8.182600E-01 |
| N1-vs-N2 |
4.981600E-01 |
|
|
